Characterization of TIM3 and its ligands in colorectal cancer | Caris Life Sciences
Portal
Order

MI Cancer Seek™ is now available for clinical ordering. Learn more.

Home / Research / Publications / Characterization of TIM3 and its ligands in colorectal cancer

Publications

Back

Characterization of TIM3 and its ligands in colorectal cancer

– Caris Life Sciences

Poster

Key Finding:

Strong associations were identified for GAL9/TIM3 expression and immuno-oncology markers, distinct molecular features, CMS, tumor microenvironment cell infiltration, and patient outcomes in colorectal cancer. 

Download Publication

Discover
More

  • The prognostic significance of TP53 mutations in patients with right-sided and left-sided colorectal cancer

    – Caris Life Sciences

    Poster

    Key Finding: While the prevalence of gain-of-function and non-gain-of-function TP53 mutations is higher in left-sided colorectal cancer versus right-sided, these mutations are associated with a… […]

  • Molecular diagnostics of colorectal cancer

    – Caris Life Sciences

    Manuscript

    Context: Of all gastrointestinal tract epithelial malignancies, molecular diagnostics has impacted colorectal cancer the most. Molecular testing can detect sporadic and inherited colorectal cancers that arise… […]
Learn More

Ready to Get Started on the Journey?

Name(Required)